UGT1A基因的遗传多态性对底物代谢的影响

尿苷二磷酸葡萄糖醛酸转移酶(UGT-Glucuronosyltransferase)是一种对许多内源性和外源性物质进行解毒,加强其排泄的重要酶类。UGT超基因家族分为两个大家族,即:UGT1和UGT2。研究表明,UGT1基因的遗传多态性对减轻药物的毒副作用和预测肿瘤的高危因素有重要的临床意义。     

体外研究UGT2B7基因SNP rs28365062对霉酚酸酯代谢的影响

目的:体外研究尿苷二磷酸葡萄糖醛酸转移酶(UGT2B7)基因SNP rs28365062对霉酚酸酯(MMF)代谢的影响,明确该位点变异是否与MMF副作用具有潜在关系。方法:采用基因重组、定点突变技术构建UGT2B7基因SNP rs28365062不同等位基因过表达载体,POLO3000转染法将重组过表达载体转染HEK293细胞,采用液相色谱-质谱联用仪(LC/MS/MS)系统检测霉酚酸(MPA)代谢产物--酰基化葡萄糖醛酸化物(Ac MPAG)24小时的生成量来评估转染不同等位基因细胞的酶活性。结果:成功构建过表达载体p IRES2-EGFP-prom(A)和p IRES2-EGFP-prom(G)并转染至HEK293细胞。LC/MS/MS系统检测结果显示携带G等位基因的突变型UGT2B7代谢MMF产生Ac MPAG的能力降低,产物Ac MPAG 24小时的生成量仅为野生型的18.60%(P0.001)。结论:UGT2B7基因SNP rs28365062可显著影响MMF代谢产物Ac MPAG的生成,可能是导致病人对MMF产生不同程度副作用的因素之一。     

药用植物中UGT家族研究进展

尿苷二磷酸葡萄糖醛酸转移酶(UDP-glucuronosyltransferase,UGT)家族是植物体内最大的糖基转移酶家族。编码合成UGT的基因属于UGT基因家族。UGT催化的糖基化反应广泛地存在于药用植物次生代谢物质的合成过程中。作为代谢通路中的下游修饰,供体分子在UGT的催化下,将糖基连接到受体分子上。这一过程往往会改变终产物的理化及生物学性质,最终影响其实际的利用价值及利用方式。本文综述分析了药用植物UGT家族基因挖掘分析、功能验证和生产应用等方面近年来的研究进展。     

尿苷二磷酸葡萄糖醛酸转移酶基因UGT1A7基因多态性与肝硬化易感性关系的研究

目的:探讨UGT1A7基因多态性与肝硬化易感性之间的关系.方法:设置150例肝硬化汉族住院患者组与100例性别/年龄相匹配的志愿者对照组,采用聚合酶链反应-限制性片段长度多态性分析法(PCR-RFLP)检测肝硬化组与正常组中UGT1A7的基因多态性,并进行统计学分析.结果:肝硬化组中C2等位基因型与对照组相比明显升高,P＜0.001,差异有显著性意义.结论:肝硬化与UGT1A7基因相关,UGT1A7等位基因C2可能是肝硬化发生的危险因素.     

家蚕核型多角体病毒egt基因的分子进化分析

过PCR方法获得家蚕核型多角体病毒（Bombyx mori nuclearpolyhedrosis virus,BmNPV）的蜕皮甾体尿苷二磷酸葡萄糖基转移酶基因（egt）片段,序列分析表明该片段带有EGT的完整ORF,推测的多肽可形成EGT结构域的高级结构。为了研究egt的起源,利用家蚕基因组数据库,电子克隆了多个家蚕尿苷二磷酸葡萄糖醛酸转移酶（UGT）基因,在此基础上进行了进化分析,表明BmNPV的EGT为antennal-enriched型UGT;推测核型多角体病毒（nucleopolyhedrivirus,NPV）和颗粒体病毒（granulovirus,GV）的egt基因在进化上来源于昆虫的UGT基因,但GV的egt基因在进化上的起源可能要早于NPV的egt基因;可能在昆虫祖先种进化形成不同昆虫目的某一时期,杆状病毒的祖先种从昆虫中获得了antennal-enriched型UGT基因,并进化为egt基因。家蚕的部分UGT基因与转座子元件连锁的基因组结构特点反映了杆状病毒的egt基因可能通过转座子的传递而获得。     

UGT1A1基因多态性和肠道菌群紊乱与伊立替康化疗相关性腹泻的相关性

腹泻是伊立替康(Irinotecan,CPT-11)化疗最常见的不良反应之一,严重影响患者的生活质量和生存。研究表明,尿苷二磷酸葡醛酰转移酶1A1(UGT1A1)基因的多态性可能是影响CPT-11化疗后腹泻等不良反应的原因之一,其中UGT1A1*28是研究最为广泛的基因位点。另一方面,近年来有研究报道,CPT-11化疗后腹泻与肠道菌群紊乱有关,尤其与产β-葡萄糖醛酸酶(β-Glucuronidase)的细菌增多有关。本文就这两大方面对CPT-11化疗相关性腹泻的研究进展作一综述。     

绞股蓝对大鼠肝组织内细胞色素P450和GST、UGT活性的影响

SD 大鼠自由饮用绞股蓝汁(绞股蓝汁每天新鲜配制,浓度为每100 g 水2 g 茶叶,100℃的水温浸泡30 min,取上清液),连续给药60 d,取出肝脏,用差速离心法制备肝脏胞浆液及肝脏微粒体,采用双光束紫外分光光度法测定 CYP3A、CYP2E1、NADPH-细胞色素 C 还原酶、UGT、GST 的活性及细胞色素 b5的含量,结果显示绞股蓝可显著升高细胞色素 b5的含量,显著诱导 CYP3A、UGT、GST、NADPH-细胞色素 C 还原酶的活性,但对 CYP2E1没有影响。提示绞股蓝与药物合用时,在体内可能会发生代谢性药物相互作用。     

siRNA干扰UGT1A1基因表达对结直肠癌细胞CPT-11化疗敏感性的影响

目的:研究siRNA干扰UGT1A1基因表达对HT-29细胞CPT-11化疗敏感性的影响.方法:realtime PCR,western blot方法检测UGT1A1 mRNA和蛋白表达.采用四甲基偶氮唑蓝显色法(MTT)观察HT-29细胞对CPT-11化疗敏感性的影响.结果:UGT1A1-siRNA可显著抑制HT-29细胞中UGT1A1 mRNA和蛋白的表达(P<0.01).Con组与MOCK组IC50值分别为25.13和24.87,干扰组IC50值为12.23(P<0.05,VS Con或MOCK组).结论:转染UGT1A1-siRNA可显着增加结直肠癌HT-29细胞对CPT-11化疗的敏感性.     

来源于蓝藻、铜绿微囊藻的尿苷二磷酸葡萄糖脱氢酶基因的克隆和鉴定

以已知的尿苷二磷酸葡萄糖脱氢酶基因的保守区为基础,自行设计一对简并引物,该对引物从形成水华的蓝藻(Synechocystis PCC6803)铜绿微囊藻FACHB 905株(Microcystis aeruginosa FACHB 905)的基因组DNA中扩增到一个476 bp的DNA片段.通过TAIL-PCR和连接介导的PCR两种方法分离该片段的侧翼序列,最后得到大小约2.5 kb的DNA片段.序列分析揭示其中有一个编码462个氨基酸的开放阅读框,我们将此开放阅读框对应的蛋白命名为Mud.该Mud蛋白的氨基酸序列与蓝藻(73%相同,87%相似)和细菌(Bacillus subtilis)(51%相同,67%相似)的尿苷二磷酸葡萄糖脱氢酶氨基酸序列表现高度的同源性.将该mud基因克隆于p-GEX-4T-1融合表达载体并在大肠杆菌中表达GST-Mud融合蛋白,经过酶活力测定发现,GST-Mud蛋白具有一定的尿苷二磷酸葡萄糖脱氢酶活性.用抗GST-Mud蛋白的多抗对M.aeruginosa FACHB 905的胞质蛋白组分进行Western印迹分析,结果显示一条分子量大小约49 kD的专一条带,这个分子量与从基因推断出的蛋白分子量大小基本一致.综上所述,我们认为从微囊藻克隆到的Mud蛋白基因是尿苷二磷酸葡萄糖脱氢酶基因,该酶在其他生物如植物和细菌中参与多糖合成,是多糖合成的关键酶之一,而在藻类中对尿苷二磷酸葡萄糖脱氢酶开展研究却是首次报道.     

来源于蓝藻、铜绿微囊藻的尿苷二磷酸葡萄糖脱氢酶基因的克隆和鉴定

以已知的尿苷二磷酸葡萄糖脱氢酶基因的保守区为基础,自行设计一对简并引物,该对引物从形成水华的蓝藻（Synechocystis PCC6803)铜绿微囊藻FACHB 905株(Microcystis aeruginosa FACHB 905)的基因组DNA中扩增到一个476bp的DNA片段。通过TAIL-PCR和连接介导的PCR两种方法分离该片段的侧翼序列,最后得到大小约2．5kb的DNA片段。序列分析揭示其中有一个编码462个氨基酸的开放阅读框,我们将此开放阅读框对应的蛋白命名为Mud。该Mud蛋白的氨基酸序列与蓝藻(73％相同,87％相似)和细菌(Bacillus subtilis)(51％相同,67％相似)的尿苷二磷酸葡萄糖脱氢酶氨基酸序列表现高度的同源性。将该mud基因克隆于p-GEX-4T-1融合表达载体并在大肠杆菌中表达GST—Mud融合蛋白,经过酶活力测定发现,GST—Mud蛋白具有一定的尿苷二磷酸葡萄糖脱氢酶活性。用抗GST-Mud蛋白的多抗对Maeruginosa FACHB 905的胞质蛋白组分进行Western印迹分析,结果显示一条分子量大小约49kD的专一条带,这个分子量与从基因推断出的蛋白分子量大小基本一致。综上所述,我们认为从微囊藻克隆到的Mud蛋白基因是尿苷二磷酸葡萄糖脱氢酶基因,该酶在其他生物如植物和细菌中参与多糖合成,是多糖合成的关键酶之一,而在藻类中对尿苷二磷酸葡萄糖脱氢酶开展研究却是首次报道。     

Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1

UDP-glucuronosyltransferase 1A1 (UGT1A1) plays an important physiological role by contributing to the metabolism of endogenous substances such as bilirubin in addition to xenobiotics and drugs. The UGT1A1 gene has been shown to be inducible by nuclear receptors steroid xenobiotic receptor (SXR) and the constitutive active receptor, CAR. In this report, we show that in human hepatoma HepG2 cells the UGT1A1 gene is also inducible with aryl hydrocarbon receptor (Ah receptor) ligands such as 2,3,7,8-tetrachlodibenzo-p-dioxin (TCDD), beta-naphthoflavone, and benzo[a]pyrene metabolites. Induction was monitored by increases in protein and catalytic activity as well as UGT1A1 mRNA. To examine the molecular interactions that control UGT1A1 expression, the gene was characterized and induction by Ah receptor ligands was regionalized to bases -3338 to -3287. Nucleotide sequence analysis of this UGT1A1 enhancer region revealed a xenobiotic response element (XRE) at -3381/-3299. The dependence of the XRE on UGT1A1-luciferase activity was demonstrated by a loss of Ah receptor ligand inducibility when the XRE core region (CACGCA) was deleted or mutated. Gel mobility shift analysis confirmed that TCDD induction of nuclear proteins specifically bound to the UGT1A1-XRE, and competition experiments with Ah receptor and Arnt antibodies demonstrated that the nuclear protein was the Ah receptor. These observations reveal that the Ah receptor is involved in human UGT1A1 induction.     

Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling

Conjugation by UDP-Glucuronosyltransferase (UGT) is the major pathway of androgen metabolism and elimination in the human. High concentrations of glucuronide conjugates of androsterone (ADT) and androstane-3alpha,17beta-diol (3alpha-diol) are present in circulation and several studies over the last 30 years have concluded that the serum levels of these metabolites might reflect the androgen metabolism in several tissues, including the liver and androgen target tissues. Three UGT2B enzymes are responsible for the conjugation of DHT and its metabolites ADT and 3alpha-diol: UGT2B7, B15 and B17. UGT2B7 is expressed in the liver and skin whereas UGT2B15 and B17 were found in the liver, prostate and skin. Very specific antibodies against each UGT2B enzyme have been obtained and used for immunohistochemical studies in the human prostate. It was shown that UGT2B17 is expressed in basal cells whereas UGT2B15 is only localized in luminal cells, where it inactivates DHT. By using LNCaP cells, we have also demonstrated that the expression and activity of UGT2B15 and B17 are modulated by several endogenous prostate factors including androgen. Finally, to study the physiological role of UGT2B enzymes, transgenic mice bearing the human UGT2B15 gene were recently obtained. A decrease in reproductive tissue weight from transgenic animals compared to those from control animals was observed. In conclusion, the conjugation by UGT2B7, B15 and B17, which represents a non-reversible step in androgen metabolism, is an important means by which androgens are regulated locally. It is also postulated that UGT enzymes protect the tissue from deleteriously high concentrations of active androgen.     

Enantioselective Inhibition of Carprofen Towards UDP‐glucuronosyltransferase (UGT) 2B7

UDP‐glucuronosyltransferases (UGTs)‐catalyzed glucuronidation conjugation reaction plays an important role in the elimination of many important clinical drugs and endogenous substances. The present study aims to investigate the enantioselective inhibition of carprofen towards UGT isoforms. In vitro a recombinant UGT isoforms‐catalyzed 4‐methylumbelliferone (4‐MU) glucuronidation incubation mixture was used to screen the inhibition potential of (R)‐carprofen and (S)‐carprofen towards multiple UGT isoforms. The results showed that (S)‐carprofen exhibited stronger inhibition potential than (R)‐carprofen towards UGT2B7. However, no significant difference was observed for the inhibition of (R)‐carprofen and (S)‐carprofen towards other UGT isoforms. Furthermore, the inhibition kinetic behavior was compared for the inhibition of (S)‐carprofen and (R)‐carprofen towards UGT2B7. A Lineweaver–Burk plot showed that both (S)‐carprofen and (R)‐carprofen exhibited competitive inhibition towards UGT2B7‐catalyzed 4‐MU glucuronidation. The inhibition kinetic parameter (K_i) was calculated to be 7.0 μM and 31.1 μM for (S)‐carprofen and (R)‐carprofen, respectively. Based on the standard for drug–drug interaction, the threshold for (S)‐carprofen and (R)‐carprofen to induce a drug–drug interaction is 0.7 μM and 3.1 μM, respectively. In conclusion, enantioselective inhibition of carprofen towards UDP‐glucuronosyltransferase (UGT) 2B7 was demonstrated in the present study. Using the in vitro inhibition kinetic parameter, the concentration threshold of (S)‐carprofen and (R)‐carprofen to possibly induce the drug–drug interaction was obtained. Therefore, clinical monitoring of the plasma concentration of (S)‐carprofen is more important than (R)‐carprofen to avoid a possible drug–drug interaction between carprofen and the drugs mainly undergoing UGT2B7‐catalyzed metabolism. Chirality 27:189–193, 2015. © 2014 Wiley Periodicals, Inc.     

Disruption of the ugt1 locus in mice resembles human Crigler-Najjar type I disease

The 9 UDP-glucuronosyltranferases (UGTs) encoded by the UGT1 locus in humans are key enzymes in the metabolism of most drugs as well as endogenous substances such as bile acids, fatty acids, steroids, hormones, neurotransmitters, and bilirubin. Severe unconjugated hyperbilirubinemia in humans that suffer from Crigler-Najjar type I disease results from lesions in the UGT1A1 gene and is often fatal. To examine the physiological importance of the Ugt1 locus in mice, this locus was rendered non-functional by interrupting exon 4 to create Ugt1(-/-) mice. Because UGT1A1 in humans is responsible for 100% of the conjugated bilirubin, it followed that newborn Ugt1(-/-) mice developed serum levels of unconjugated bilirubin that were 40-60 times higher than Ugt1(+/-) or wild-type mice. The result of extreme unconjugated bilirubin in Ugt1(-/-) mice, comparable to the induced levels noted in patients with Crigler-Najjar type 1 disease, is fatal in neonatal Ugt1(-/-) mice within 2 weeks following birth. The extreme jaundice is present as a phenotype in skin color after 8 h. Neonatal Ugt1(-/-) mice exhibit no detectable UGT1A-specific RNA, which corresponds to a complete absence of UGT1A proteins in liver microsomes. Conserved glucuronidation activity attributed to the Ugt1 locus can be defined in Ugt1(-/-) mice, because UGT2-dependent glucuronidation activity is unaffected. Remarkably, the loss of UGT1A functionality in liver results in significant alterations in cellular metabolism as investigated through changes in gene expression. Thus, the loss of UGT1A function in Ugt1(-/-) mice leads to a metabolic syndrome that can serve as a model to further investigate the toxicities associated with unconjugated bilirubin and the impact of this disease in humans.     

Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells

Androgens are major regulators of prostate cell growth and physiology. In the human prostate, androgens are inactivated in the form of hydrophilic glucuronide conjugates. These metabolites are formed by the two human UGT2B15 [UGT (UDP-glucuronosyltransferase) 2B15] and UGT2B17 enzymes. The FXR (farnesoid X receptor) is a bile acid sensor controlling hepatic and/or intestinal cholesterol, lipid and glucose metabolism. In the present study, we report the expression of FXR in normal and cancer prostate epithelial cells, and we demonstrate that its activation by chenodeoxycholic acid or GW4064 negatively interferes with the levels of UGT2B15 and UGT2B17 mRNA and protein in prostate cancer LNCaP cells. FXR activation also causes a drastic reduction of androgen glucuronidation in these cells. These results point out activators of FXR as negative regulators of androgen-conjugating UGT expression in the prostate. Finally, the androgen metabolite androsterone, which is also an activator of FXR, dose-dependently reduces the glucuronidation of androgens catalysed by UGT2B15 and UGT2B17 in an FXR-dependent manner in LNCaP cells. In conclusion, the present study identifies for the first time the activators of FXR as important regulators of androgen metabolism in human prostate cancer cells.     

Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme

Glucuronidation, a major metabolic pathway for a large variety of endobiotics and xenobiotics, is catalyzed by enzymes belonging to the UDP-glucuronosyltransferase (UGT) family. Among UGT enzymes, UGT2B4 conjugates a large variety of endogenous and exogenous molecules and is considered to be the major bile acid conjugating UGT enzyme in human liver. In the present study, we identify UGT2B4 as a novel target gene of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR alpha), which mediates the hypolipidemic action of fibrates. Incubation of human hepatocytes or hepatoblastoma HepG2 and Huh7 cells with synthetic PPAR alpha agonists, fenofibric acid, or Wy 14643 resulted in an increase of UGT2B4 mRNA levels. Furthermore, treatment of HepG2 cells with Wy 14643 induced the glucuronidation of hyodeoxycholic acid, a specific bile acid UGT2B4 substrate. Analysis of UGT2B mRNA and protein levels in PPAR alpha wild type and null mice revealed that PPAR alpha regulates both basal and fibrate-induced expression of these enzymes in rodents also. Finally, a PPAR response element was identified in the UGT2B4 promoter by site-directed mutagenesis and electromobility shift assays. These results demonstrate that PPAR alpha agonists may control the catabolism of cytotoxic bile acids and reinforce recent data indicating that PPAR alpha, which has been largely implicated in the control of lipid and cholesterol metabolism, is also an important modulator of the metabolism of endobiotics and xenobiotics in human hepatocytes.     

Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases

Arachidonic acids (AA) and linoleic acids (LAs) are metabolized, in several tissues, to hydroxylated metabolites that are important mediators of many physiological and pathophysiological processes. The conjugation of leukotriene B4 (LTB4), 5-hydroxyeicosatetraenoic acid (HETE), 12-HETE, 15-HETE, and 13-hydroxyoctadecadienoic acid (HODE) by the human UDP-glucuronosyltransferase (UGT) enzymes was investigated. All substrates tested were efficiently conjugated by human liver microsomes to polar derivatives containing the glucuronyl moiety as assessed by mass spectrometry. The screening analyses with stably expressed UGT enzymes in HK293 showed that glucuronidation of LTB4 was observed with UGT1A1, UGT1A3, UGT1A8, and UGT2B7, whereas UGT1A1, UGT1A3, UGT1A4, and UGT1A9 also conjugated most of the HETEs and 13-HODE. LA and AA metabolites also appear to be good substrates for the UGT2B subfamily members, especially for UGT2B4 and UGT2B7 that conjugate all HETE and 13-HODE. Interestingly, UGT2B10 and UGT2B11, which are considered as orphan enzymes since no conjugation activity has so far been demonstrated with these enzymes, conjugated 12-HETE, 15-HETE, and 13-HODE. In summary, our data showed that several members of UGT1A and UGT2B families are capable of converting LA and AA metabolites into glucuronide derivatives, which is considered an irreversible step to inactivation and elimination of endogenous substances from the body.     

Peroxisome proliferators as inducers and substrates of UDP-glucuronosyltransferases

Summary— Peroxisome proliferators, despite their chemically unrelated structures, share the common property of being able to stimulate the glucuronidation of bilirubin in rodents and, probably, also in man. The aryloxycarboxylic acids (clofibric acid, fenofibrate, bezafibrate, ciprofibrate), tiadenol and probucol, all of which have hypolipidemic properties, as well as the fatty acid-like perfluorodecanoic acid all enhanced the expression of the UDP-glucuronosyltransferase (UGT) form involved in the conjugation of the pigment. This induction is manifested by an increase in the mRNA species encoding the protein with a subsequent increase in the neosynthesis of the corresponding protein in the endoplasmic reticulum. The induction process is concomitant with that of cytochrome P-450-IVA1 and cytosolic epoxide hydrolase, which, like bilirubin UGT, are mainly involved in the metabolism of endogenous substrates. With a series of carboxylic acids related to clofibric acid, it was possible to demonstrate that induction was mediated via specific interactions based on the physicochemical properties of the inducers. Until now, the molecular basis of induction of bilirubin UGT is not known. The peroxisome proliferators that possess a carboxyl group are good substrates of UGT, especially in man. The acylglucuronides formed are known for their instability and reactivity which could contribute to the toxicity encountered in some patients treated with the drugs. There is convincing evidence that UGT bilirubin does not catalyze the glucuronidation of these substances even if the two types of substrate form acylglucuronides.